about
Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplifi...
Read More
1.53
-0.05
(-3.16%)
115.9K
XNAS Volume
XNAS 07 May, 2026 5:30 PM (EDT)
Board Meeting
The board meeting for Boundless Bio Inc is scheduled for today, for the purpose of Boundless Bio Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Boundless Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..